Angiogenesis in bladder cancer--prognostic marker and target for future therapy

Surg Oncol. 2002 Jun;11(1-2):85-100. doi: 10.1016/s0960-7404(02)00013-0.

Abstract

Angiogenesis is the process by which tumours induce a blood supply, crucial for growth and metastasis. Evidence for its role in bladder carcinogenesis, its usefulness as a marker of patient prognosis, and potential anti-angiogenic therapies for future development are discussed in this chapter.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inducing Agents / biosynthesis*
  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Cyclohexanes
  • DNA-Binding Proteins
  • Drug Combinations
  • Endothelial Growth Factors / biosynthesis
  • Humans
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Lymphokines / biosynthesis
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic / complications*
  • Neovascularization, Pathologic / metabolism
  • Nuclear Proteins
  • O-(Chloroacetylcarbamoyl)fumagillol
  • Piperidines
  • Quinazolines / administration & dosage
  • Quinazolinones
  • Sesquiterpenes / administration & dosage
  • Thymidine Phosphorylase / metabolism
  • Transcription Factors*
  • Urinary Bladder Neoplasms / blood supply*
  • Urinary Bladder Neoplasms / metabolism
  • Urinary Bladder Neoplasms / therapy
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inducing Agents
  • Angiogenesis Inhibitors
  • Cyclohexanes
  • DNA-Binding Proteins
  • Drug Combinations
  • Endothelial Growth Factors
  • HIF1A protein, human
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Lymphokines
  • Nuclear Proteins
  • Piperidines
  • Quinazolines
  • Quinazolinones
  • Sesquiterpenes
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Thymidine Phosphorylase
  • halofuginone
  • O-(Chloroacetylcarbamoyl)fumagillol